GlobeNewsWire
30 Jun 2026, 13:19 UTC · 11w ago
Verdict
Headline takes no side. We score ADMA −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Culper Research alleges ADMA Biologics engaged in channel stuffing to report 20% growth in 2025 when real growth was allegedly -3%.
So whatAllegations of fraudulent revenue inflation and significant overstatement of growth typically lead to severe valuation corrections.
More negative than 99% of claims this week
Lowey Dannenberg P.C. is investigating ADMA Biologics for potential violations of federal securities laws.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 92% of claims this week
Culper Research claims ADMA Biologics used rebates and extended payment terms to induce distributors to stock excess ASCENIV.
More negative than 81% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is under investigation for potential securities law violations and alleged revenue inflation via channel stuffing.
More negative than 88% of ticker scores this week
The company is being investigated by a law firm for potential securities law violations.
More negative than 88% of ticker scores this week
The company is being investigated by a law firm for potential securities law violations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1d ago
+8.8%
Price is moving against the score
$9.11 vs $8.37 close before publication (Jun 29) · not market-adjusted
ADMA chart →
